Media Center

FAST/Fellows/CARB-X Round-Up July 2018

FAST & Fellows Round-Up

  • Ligandal (FAST Spring 2016) listed in top 9 CRISPR startup companies changing the future of biotech and medicine Read More
  • MicroSynbiotiX (FAST Fall 2017) shows feasibility of their microalgae platform to deliver oral vaccines to fish Read More
  • Pheronym (FAST Fall 2017) wins the Florida-Israel Innovation Partnership Award for their eco-friendly pest control for interstellar agriculture Read More

CARB-X Updates

  • Powered by CARB-X company, Talis Biomedical was awarded a $5.6M grant from NIAID/NIH to fund the development of a clinically impactful Point-of-Care diagnostics for antimicrobial resistant bacteria Read More
  • Powered by CARB-X company, Achaogen launched ZEMDRI™ (plazomicin), a once daily aminoglycoside for use in complicated urinary tract infections (cUTI) Read More
  • Powered by CARB-X company, BugWorks featured in a Bloomberg article: The Startups Waging War Against Superbugs: India is on the front line of the battle to prevent a post-antibiotic world Read More
  • Powered by CARB-X company, T2 Biosystems featured in STAT News article: Sepsis is the third leading cause of death. Can a new blood test change that? Read More
  • Powered by CARB-X company, Entasis Therapeutics joins the Antimicrobials Working Group to combat drug resistant infections and spur life-saving innovations Read More
  • CARB-X awards up to $4.5 million to Summit Therapeutics to support the development of a new class of antibiotic compounds addressing a novel target to treat gonorrhea Read More
  • Powered by CARB-X company, Antabio SAS, announced it has extended its Series A financing round with an additional €5.2 million with new investors BNP Paribas Développement and Sham Innovation Santé, and from existing shareholder Galia Gestion Read More